ResMed price target raised to A$41 from A$38 at Citi
Citi analyst Mathieu Chevrier raised the firm’s price target on ResMed (RMD) to A$41 from A$38 and keeps a Neutral rating on the shares ...
ResMed price target raised to $260 from $252 at Piper Sandler
Piper Sandler analyst Adam Maeder raised the firm’s price target on ResMed (RMD) to $260 from $252 and keeps a Neutral rating on the shares.
fnarena6d
ResMed: Another Positive Quarterly Surprise?
UBS makes a similar comment, stating ResMed shares are trading at 23x FY26 earnings. Although this represents a 40% premium ...
Business Insider5y
My dad can manage his sleep apnea better now with this $335 automatic mask cleaning system
One of the most common treatments for obstructive sleep apnea is continuous positive airway pressure (CPAP) applied by a ventilator, called a CPAP machine ... bundles for ResMed AirSense 10 ...
Nasdaq7d
ResMed Reaches Analyst Target Price
In recent trading, shares of ResMed Inc. (Symbol: RMD) have crossed above the average analyst 12-month target price of $253.00, changing hands for $254.70/share. When a stock reaches the target an ...